For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Organon & Co (NYSE: OGN) closed at $9.45 down -0.11% from its previous closing price of $9.46. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 3.9 million shares were traded. OGN stock price reached its highest trading level at $9.68 during the session, while it also had its lowest trading level at $9.4.
Ratios:
For a deeper understanding of Organon & Co’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.16. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 1.67. In the meantime, Its Debt-to-Equity ratio is 16.52 whereas as Long-Term Debt/Eq ratio is at 16.49.
On September 06, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral and also upped its target price recommendation from $18 to $20.
Goldman Downgraded its Buy to Neutral on November 03, 2023, whereas the target price for the stock was revised from $33 to $16.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’25 when COX CARRIE SMITH bought 12,469 shares for $8.07 per share. The transaction valued at 100,591 led to the insider holds 12,469 shares of the business.
Falcione Aaron bought 5,500 shares of OGN for $48,235 on May 07 ’25. The Chief Human Resources Officer now owns 62,974 shares after completing the transaction at $8.77 per share. On May 06 ’25, another insider, Weaver Kirke, who serves as the Gen. Counsel & Corp. Secy. of the company, bought 8,045 shares for $9.21 each. As a result, the insider paid 74,054 and bolstered with 52,489 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OGN now has a Market Capitalization of 2456584192 and an Enterprise Value of 10925374464. As of this moment, Organon’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.27, and their Forward P/E ratio for the next fiscal year is 2.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 4.50. Its current Enterprise Value per Revenue stands at 1.736 whereas that against EBITDA is 6.446.
Stock Price History:
The Beta on a monthly basis for OGN is 0.56, which has changed by -0.5608171 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, OGN has reached a high of $23.10, while it has fallen to a 52-week low of $8.01. The 50-Day Moving Average of the stock is -0.42%, while the 200-Day Moving Average is calculated to be -31.08%.
Shares Statistics:
For the past three months, OGN has traded an average of 5.63M shares per day and 3532320 over the past ten days. A total of 259.96M shares are outstanding, with a floating share count of 258.99M. Insiders hold about 0.37% of the company’s shares, while institutions hold 79.69% stake in the company. Shares short for OGN as of 1749772800 were 15952116 with a Short Ratio of 2.83, compared to 1747267200 on 15960972. Therefore, it implies a Short% of Shares Outstanding of 15952116 and a Short% of Float of 8.180001.
Dividends & Splits
According to the company, the forward annual dividend rate for OGN is 0.86, from 1.12 in the trailing year. Against a Trailing Annual Dividend Yield of 0.118393235
